Cape Verde vs Norway: HIV/AIDS deaths averted by antiretroviral therapy
Cape Verde
176.27 deaths
in 2024
Norway
168.96 deaths
in 2024
Cape Verde rank
111th
Norway rank
113th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cape Verde
- Norway
How they compare
Cape Verde currently reports 176.27 deaths against 168.96 deaths in Norway, a difference of 7.31 deaths.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Norway ahead.
Cape Verde ranks 111th and Norway ranks 113th of 157 countries.
Norway has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cape Verde | Norway | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 24.26 deaths | 24.26 deaths | Norway |
| 2000s | 37.38 deaths | 111.82 deaths | 74.44 deaths | Norway |
| 2010s | 125.26 deaths | 182.68 deaths | 57.42 deaths | Norway |
| 2020s | 164.69 deaths | 180.2 deaths | 15.51 deaths | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cape Verde or Norway?
- Cape Verde, at 176.27 deaths against 168.96 deaths in Norway as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cape Verde and Norway?
- 7.31 deaths, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Norway?
- 35 years are reported by both, from 1990 to 2024.
- How do Cape Verde and Norway rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cape Verde ranks 111th and Norway ranks 113th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.